RXO, Inc.

Fundamentals5.0
Price Action5.0
News Sentiment5.0
AI Rating
6.0

Key Drivers

  • Large revenue base
  • Cash-flow strain
  • High operating costs

AI
AI Summary

6.0

RXO's shift into a tech-led brokerage (LTL mix expansion, Coyote scale, >$185m annualized cost saves and ~$100m/yr AI spend) reframes it from a cyclical spot play to a higher-conviction operational-improvement story, but thin cash balances, volatile near-term EBITDA and execution/refinancing risk mean investors should hold/watch until margin recovery and cash stabilization are demonstrable.

OperationalTurnaround
LiquidityRisk
BrokerageShift‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

5.0

Key Financial Insights:

  • Large revenue base
  • Cash-flow strain
  • High operating costs

RXO combines scale and a low price-to-sales with manageable headline leverage but is undermined by full-year net losses, tight cash flow, rising quarterly pressure, high opex, and large intangibles.

Caution
Scale

Price Behavior

5.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Below SMA
  • Oversold momentum
  • Support-tested recently

RXO is in a short-term downtrend with the close at $13.23 below the last-month SMA (~$14.25), RSI ~27 shows oversold conditions, and key risk is a break below $11.96 while resistance sits near $16.53 (and $15–$16).

bearish
oversold
Support Level: $11.96
Resistance Level: $16.53; range $15.00–$16.00; immediate resistance $14.25

Rapid drop to $11.96 on 2026-03-16 highlighted recent downside pressure

Sentiment & News

5.0

Key News Insights:

  • Investor events
  • Insider-heavy ownership
  • Mixed analyst sentiment

RXO increased investor engagement and executive recognition in late Feb–Mar 2026 but faced mixed analyst sentiment and near-term share weakness amid volatile trading ( )

RXO
volatility

The outreach and awards may support long-run credibility, but muted analyst ratings and recent share declines suggest limited near-term upside until guidance or fundamentals improve